VVOS logo

VVOS
Vivos Therapeutics Inc

5,435
Mkt Cap
$8.13M
Volume
111,364.00
52W High
$7.95
52W Low
$0.545
PE Ratio
-0.25
VVOS Fundamentals
Price
$0.6338
Prev Close
$0.5848
Open
$0.599
50D MA
$1.00
Beta
0.83
Avg. Volume
401,147.96
EPS (Annual)
-$2.06
P/B
-6.93
Rev/Employee
$65,085.82
$32.27
Loading...
Loading...

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available

Earnings Recap

• Reported GAAP EPS of -$0.52 down -15.56% YoY • Reported revenue of $5.14M up 70.46% YoY

Bullish

Vivos Therapeutics Inc achieved 70% revenue growth to $5.1M and expanded gross margin to 60% in Q1 2026, driven by its new medical provider-focused model. The company also successfully raised $6.1M in financing.

Bearish

Vivos Therapeutics Inc faces substantial doubt about its going concern status due to widening losses and insufficient cash. Nasdaq non-compliance and operational challenges with the SCN acquisition and clinical trial further pressure Vivos Therapeutics Inc.